U2Bio Co., Ltd. engages in the provision of in vitro diagnostics and medical information technology (IT) services. It operates through the following business areas: In vitro diagnostics services, Medical IT Solutions, and New Business. In vitro diagnostics business offers general diagnostic tests, molecular diagnostic tests, and research authorization clinical services. The Medical IT solution business provides medical practitioner-centered health examination, specialized medical examination and diagnostic equipment, and electronic medical record interworking solutions. The New Business area focuses on clinical trial services and personalized healthcare solutions. The company was founded on January 2, 2009 and is headquartered in Seoul, South Korea.